Acute hypertriglyceridemia in patients with COVID-19 receiving tocilizumab.

Morrison, Austin R; Johnson, Joseph M; Ramesh, Mayur; Bradley, Patrick; Jennings, Jeffery; Smith, Zachary R

Morrison, Austin R; Johnson, Joseph M; Ramesh, Mayur; Bradley, Patrick; Jennings, Jeffery; Smith, Zachary R.

Morrison AR; Department of Pharmacy, Henry Ford Hospital, Detroit, Michigan.
Johnson JM; Department of Pharmacy, Henry Ford Hospital, Detroit, Michigan.
Ramesh M; Department of Infectious Diseases, Henry Ford Hospital, Detroit, Michigan.
Bradley P; Pulmonary and Critical Care Medicine Division, Henry Ford Hospital, Detroit, Michigan.
Jennings J; Pulmonary and Critical Care Medicine Division, Henry Ford Hospital, Detroit, Michigan.
Smith ZR; Department of Pharmacy, Henry Ford Hospital, Detroit, Michigan.

J Med Virol ; 92(10): 1791-1792, 2020 10.

Article in English | MEDLINE | ID: covidwho-968324

Subject(s)

COVID-19; Hypertriglyceridemia; Pneumonia, Viral; Antibodies, Monoclonal, Humanized; Humans; Hypertriglyceridemia/chemically induced; Pandemics; Pneumonia, Viral/epidemiology; SARS-CoV-2

Keywords

coronavirus; disease control; immune responses; immunodulators; interleukin; virus classification

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Hypertriglyceridemia / COVID-19 Type of study: Observational study Limits: Humans Language: English Journal: J Med Virol Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google